{"title":"Urine Protein Tests in Systematic Lupus Erythematosus: What Do They Mean?","authors":"Mona Aflaki, Joanne M Bargman","doi":"10.3899/jrheum.2024-0910","DOIUrl":null,"url":null,"abstract":"<p><p>The development of lupus nephritis (LN) in patients with systemic lupus erythematosus is associated with increased morbidity and mortality. Proteinuria is a key indicator of kidney involvement; detecting and monitoring proteinuria is therefore crucial as it acts as a surrogate marker for disease activity and has significant prognostic value. This review explores the general mechanisms of proteinuria and highlights the limitations of current measurement techniques. In the absence of specific urinary markers for LN disease activity, evaluating proteinuria involves considering its trajectory, amplitude of change, and the overall clinical status of the patient. Differentiating between acute disease vs proteinuria that may stem from scarring and glomerular basement membrane remodeling can be challenging. Additionally, in the absence of other signs of active disease, the time to recovery and resolution of proteinuria may be prolonged.</p>","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3899/jrheum.2024-0910","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The development of lupus nephritis (LN) in patients with systemic lupus erythematosus is associated with increased morbidity and mortality. Proteinuria is a key indicator of kidney involvement; detecting and monitoring proteinuria is therefore crucial as it acts as a surrogate marker for disease activity and has significant prognostic value. This review explores the general mechanisms of proteinuria and highlights the limitations of current measurement techniques. In the absence of specific urinary markers for LN disease activity, evaluating proteinuria involves considering its trajectory, amplitude of change, and the overall clinical status of the patient. Differentiating between acute disease vs proteinuria that may stem from scarring and glomerular basement membrane remodeling can be challenging. Additionally, in the absence of other signs of active disease, the time to recovery and resolution of proteinuria may be prolonged.
期刊介绍:
The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 41 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.